Bharat Biotech’s 'Covaxin' gets DCGI nod for phase 2, 3 clinical trials on children aged 2 to 18 years



from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2R6SOXH
via IFTTT

0 comments:

Post a Comment